Suicidal Ideation and Behavior in Korean Adolescents With Depression

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2011 by Hallym University Medical Center.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
Bundang CHA Hospital
Myongji Hospital
Information provided by (Responsible Party):
Hallym University Medical Center
ClinicalTrials.gov Identifier:
NCT01314521
First received: March 9, 2011
Last updated: October 4, 2011
Last verified: March 2011
  Purpose

The purpose of this study is to examine clinical characteristics of Korean adolescents with depression who have suicidal ideation and behavior. We formulate those hypotheses.

  1. Being bullied in peer relationships, excessive use of internet, excessive extra-curricular tutoring, sexual abuse in childhood, physical abuse and emotional neglect are risk factors of suicide in adolescents.
  2. Depression of parents and negative child-rearing attitude are risk factors of suicidal ideation and behavior in adolescents.
  3. Emotional quotient (EQ) and resilience of adolescent are protective factors of suicide.

Condition
Depression

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Suicidal Ideation and Behavior in Korean Adolescents With Depression

Resource links provided by NLM:


Further study details as provided by Hallym University Medical Center:

Primary Outcome Measures:
  • Columbia Suicide Severity Rating Scale; C-SSRS [ Time Frame: baseline only (at any one point during the depressive episode) ] [ Designated as safety issue: No ]
    Semi-structured clinical interview based on the systematic guideline which help draw inferences about suicidal ideation from clinical situation and risk factors related to the suicide. It is composed with three categories that are suicidal attempt (ideation), non-suicidal attempt (ideation), and potential of suicidal attempt (ideation).


Secondary Outcome Measures:
  • Beck suicidal ideation scale [ Time Frame: baseline only ] [ Designated as safety issue: No ]
    self report form of 19 items with 3 point scale. for subjects and their parents.

  • Revised Children's Manifest Anxiety Scale; RCMAS [ Time Frame: baseline only ] [ Designated as safety issue: No ]
  • Beck Depression Inventory [ Time Frame: baseline only ] [ Designated as safety issue: No ]

Estimated Enrollment: 150
Study Start Date: January 2011
Estimated Study Completion Date: March 2012
Detailed Description:

Korea has reported the highest suicide rate among OECD members and according to the data from the Korea national statistical office, suicide is the second major cause of death in adolescents and is increasing. Depression, one of the well-known risk factors of suicide in adolescents, can cause maladjustments to school and family life, problems of interpersonal relationship and drug abuse so that work to trigger the suicidal ideation and behavior. In his study, we planned to examine the relationship between suicidal ideation and behavior and several risk factors by using the standardized diagnostic clinical interview, especially an objective suicide evaluating method which has recently developed.

  Eligibility

Ages Eligible for Study:   13 Years to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

outpatients of university hospitals. 50 from Hallym University Sacred Heart Hospital, 50 from Bundang CHA Hospital, 50 from Myongji Hospital.

Criteria

Inclusion Criteria:

  • a subject who has depression (Major depressive disorder, dysthymic disorder, depressive disorder NOS) diagnosed by Kiddie-Schedule for affective disorder and schizophrenia (K-SADS-PL-K)
  • subjects and their family (a parent or a grandparent) or their legal representative consent to participate in this study voluntarily
  • subjects and their family (a parent or a grandparent) or their legal representative are able to understand the meaning of participation in this study and able to reject or ask to leave from this study

Exclusion Criteria:

  • a patient who has diagnosed with bipolar disorder, psychotic disorder, pervasive developmental disorder, organic brain disease, or epilepsy
  • a patient with mental retardation who is IQ under 70
  • a patient who has a severe medical illness (chronic physical disease, cardiovascular, hepatobiliary, nephrology, or respiratory disease and so on)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01314521

Contacts
Contact: Mina Song, MD +82-10-4760-2990 blue-oboe@hanmail.net
Contact: Hyun Ju Hong, MD, PhD +82-31-380-3751 honghj88@gmail.com

Locations
Korea, Republic of
Hallym University Sacred Heart Hospital Recruiting
Anyang Si, Kyeonggi Do, Korea, Republic of, 431-070
Contact: Hyun Ju Hong, MD, PhD    +82-31-380-3751    honghj88@gmail.com   
Contact: Mina Song, MD    +82-10-4760-2990    blue-oboe@hanmail.net   
Sponsors and Collaborators
Hallym University Medical Center
Bundang CHA Hospital
Myongji Hospital
Investigators
Principal Investigator: Hyun Ju Hong, MD, PhD Hallym University Medical Center
  More Information

No publications provided

Responsible Party: Hallym University Medical Center
ClinicalTrials.gov Identifier: NCT01314521     History of Changes
Other Study ID Numbers: SKAD
Study First Received: March 9, 2011
Last Updated: October 4, 2011
Health Authority: Korea: Institutional Review Board

Keywords provided by Hallym University Medical Center:
Suicide
Depression
Adolescents

Additional relevant MeSH terms:
Depression
Depressive Disorder
Suicidal Ideation
Behavioral Symptoms
Mood Disorders
Mental Disorders
Suicide
Self-Injurious Behavior

ClinicalTrials.gov processed this record on September 16, 2014